Avery D Posey

19PUBLICATIONS
125CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 11, 2026
Aberrant O-glycosylation Induces IL-34-Mediated Immune Remodeling and Promotes Pancreatic Cancer Progression.

|Jul 28, 2026
ST6GAL1 Glycoengineering Rewires Cytokine Signaling and Preserves Metabolic Fitness in CAR-T Cells Under Galectin-3-Mediated Immunosuppression.

|Jul 06, 2026
TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory Axis.

|Jul 03, 2026
CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance.

|Jun 13, 2026
Siglec-15 binds mucin-domain glycoproteins with extended glycans and marks an osteoclast-like, matrix remodeling myeloid state in human tumors.

|Jan 22, 2026
CD2 costimulation bridges potent CAR-induced cytolysis and durable persistence.

Fang Liu, John T Keane, Hyeon S Lewis

Pageof 4

Frequent Collaborators

3 joint publications

Fang Liu

3 joint publications

Shawna K Brookens

3 joint publications

Antonia Rotolo

2 joint publications

Yunlin Zhang